Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Aug 13, 2026
Data as of Oct 16
▼ SELL$135K1,268 shares at $106.63Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
- Traded
- Aug 13, 2026
- Disclosed
- Aug 14, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ORKA since disclosure
−35.2%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund
Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$225Kdisclosed Aug 14 · filed 1 day after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$220Kdisclosed Aug 14 · filed 1 day after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$256Kdisclosed Aug 14 · filed 1 day after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$231Kdisclosed Aug 14 · filed 1 day after the trade